Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.
Open357.400 | Close353.030 |
Vol / Avg.104.276K / 190.787K | Mkt Cap10.265B |
Day Range351.960 - 358.770 | 52 Wk Range345.530 - 509.623 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.550 | 3.000 | 0.4500 | ||||
REV | 687.880M | 681.100M | -6.780M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-07 | Wells Fargo | Dan Leonard | Maintains | OverweightOverweight | Lowers | 550.00 | 525.00 |
2023-08-04 | RBC Capital | Conor McNamara | Maintains | OutperformOutperform | Raises | 522.00 | 524.00 |
2023-08-04 | Credit Suisse | Dan Leonard | Maintains | OutperformOutperform | Lowers | 580.00 | 550.00 |
2023-06-16 | Wells Fargo | Dan Leonard | Initiates Coverage On | Overweight | Announces | - | 550.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BIO | Bio-Rad Laboratories | -1.2% | 10.3B |
MEDP | Medpace Hldgs | 0.78% | 7.4B |
A | Agilent Technologies | 1.53% | 32.6B |
TXG | 10x Genomics | -1.34% | 4.9B |
SYNH | Syneos Health | -0.07% | 4.4B |
You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.
Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Wells Fargo on Monday, August 7, 2023. The analyst firm set a price target for 525.00 expecting BIO to rise to within 12 months (a possible 48.71% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Bio-Rad Laboratories (NYSE: BIO) is $353.03 last updated Today at September 22, 2023 at 10:30 PM UTC.
There is no dividend information for Bio-Rad Laboratories.
Bio-Rad Laboratories’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bio-Rad Laboratories.
Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.